Literature DB >> 24693974

Association of plasma ortho-tyrosine/para-tyrosine ratio with responsiveness of erythropoiesis-stimulating agent in dialyzed patients.

Szilárd Kun, Esztella Mikolás, Gergo A Molnár, Eszter Sélley, Boglárka Laczy, Botond Csiky, Tibor Kovács, István Wittmann.   

Abstract

Objectives Patients with end-stage renal failure (ESRF) treated with erythropoiesis-stimulating agents (ESAs) are often ESA-hyporesponsive associated with free radical production. Hydroxyl free radical converts phenylalanine into ortho-tyrosine, while physiological isomer para-tyrosine is formed enzymatically, mainly in the kidney. Production of 'para-tyrosine' is decreased in ESRF and it can be replaced by ortho-tyrosine in proteins. Our aim was to study the role of tyrosines in ESA-responsiveness. Methods Four groups of volunteers were involved in our cross-sectional study: healthy volunteers (CONTR; n = 16), patients on hemodialysis without ESA-treatment (non-ESA-HD; n = 8), hemodialyzed patients with ESA-treatment (ESA-HD; n = 40), and patients on continuous peritoneal dialysis (CAPD; n = 21). Plasma ortho-, para-tyrosine, and phenylalanine levels were detected using a high performance liquid chromatography (HPLC)-method. ESA-demand was expressed by ESA-dose, ESA-dose/body weight, and erythropoietin resistance index1 (ERI1, weekly ESA-dose/body weight/hemoglobin). Results We found significantly lower para-tyrosine levels in all groups of dialyzed patients when compared with control subjects, while in contrast ortho-tyrosine levels and ortho-tyrosine/para-tyrosine ratio were comparatively significantly higher in dialyzed patients. Among groups of dialyzed patients the ortho-tyrosine level and ortho-tyrosine/para-tyrosine ratio were significantly higher in ESA-HD than in the non-ESA-HD and CAPD groups. There was a correlation between weekly ESA-dose/body weight, ERI1, and ortho-tyrosine/para-tyrosine ratio (r = 0.441, P = 0.001; r = 0.434, P = 0.001, respectively). Our most important finding was that the ortho-tyrosine/para-tyrosine ratio proved to be an independent predictor of ERI1 (β = 0.330, P = 0.016). In these multivariate regression models most of the known predictors of ESA-hyporesponsiveness were included. Discussion Our findings may suggest that elevation of the ratio of ortho-tyrosine/para-tyrosine could be responsible for decreased ESA-responsiveness in dialyzed patients.

Entities:  

Keywords:  Chronic; Darbepoetin alfa; Hydroxyl radical; Kidney failure; Oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 24693974      PMCID: PMC6837534          DOI: 10.1179/1351000214Y.0000000090

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  30 in total

1.  Accumulation of the hydroxyl free radical markers meta-, ortho-tyrosine and DOPA in cataractous lenses is accompanied by a lower protein and phenylalanine content of the water-soluble phase.

Authors:  Gergo A Molnár; Vanda Nemes; Zsolt Biró; Andrea Ludány; Zoltán Wagner; István Wittmann
Journal:  Free Radic Res       Date:  2005-12

2.  Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment.

Authors:  T Nguyen-Khoa; Z A Massy; J P De Bandt ; M Kebede; L Salama; G Lambrey; V Witko-Sarsat; T B Drüeke; B Lacour; M Thévenin
Journal:  Nephrol Dial Transplant       Date:  2001-02       Impact factor: 5.992

3.  Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients.

Authors:  Jérôme Rossert; Cristiana Gassmann-Mayer; Dieter Frei; William McClellan
Journal:  Nephrol Dial Transplant       Date:  2007-01-08       Impact factor: 5.992

Review 4.  Resistance to erythropoietin-stimulating agents: etiology, evaluation, and therapeutic considerations.

Authors:  Oluwatoyin Bamgbola
Journal:  Pediatr Nephrol       Date:  2011-03-20       Impact factor: 3.714

5.  Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure: evidence for hydroxyl radical production.

Authors:  Gergõ A Molnár; Zoltán Wagner; Lajos Markó; Tamás Kó Szegi; Márton Mohás; Béla Kocsis; Zoltán Matus; László Wagner; Mónika Tamaskó; István Mazák; Boglárka Laczy; Judit Nagy; István Wittmann
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

6.  Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?

Authors:  O Sommerburg; T Grune; H Hampl; E Riedel; F J van Kuijk; J H Ehrich; W G Siems
Journal:  Nephrol Dial Transplant       Date:  1998-10       Impact factor: 5.992

7.  Fenton chemistry. Amino acid oxidation.

Authors:  E R Stadtman; B S Berlett
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

8.  ORAMA: a study to investigate EBPG impact on renal anaemia - design and baseline data.

Authors:  F Locatelli; A Covic; I C Macdougall; A Wiecek
Journal:  J Nephrol       Date:  2008 Jul-Aug       Impact factor: 3.902

Review 9.  Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage.

Authors:  Anuradha Vivekanadan-Giri; Jeffrey H Wang; Jaeman Byun; Subramaniam Pennathur
Journal:  Rev Endocr Metab Disord       Date:  2008-12       Impact factor: 6.514

Review 10.  Erythropoiesis-stimulating agent hyporesponsiveness.

Authors:  David W Johnson; Carol A Pollock; Iain C Macdougall
Journal:  Nephrology (Carlton)       Date:  2007-08       Impact factor: 2.506

View more
  6 in total

Review 1.  Tyrosine isomers and hormonal signaling: A possible role for the hydroxyl free radical in insulin resistance.

Authors:  Gergő A Molnár; Esztella Zsóka Mikolás; István András Szijártó; Szilárd Kun; Eszter Sélley; István Wittmann
Journal:  World J Diabetes       Date:  2015-04-15

2.  Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidase.

Authors:  Ken Aizawa; Ryohei Kawasaki; Yoshihito Tashiro; Michinori Hirata; Koichi Endo; Yasushi Shimonaka
Journal:  Int J Hematol       Date:  2016-04-15       Impact factor: 2.490

3.  Early responsiveness to continuous erythropoietin receptor activator predicts renal prognosis and is determined by a novel antioxidative marker in non-dialysis chronic kidney disease: a prospective, observational, single-center study.

Authors:  Jun Ino; Eri Kasama; Mio Kodama; Takako Harada; Keitaro Sato; Hitoshi Eizumi; Youichiro Kawashima; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2020-03-17       Impact factor: 2.801

4.  Disturbances in Metabolic Pathways and the Identification of a Potential Biomarker Panel for Early Cartilage Degeneration in a Rabbit Anterior Cruciate Ligament Transection Model.

Authors:  Yiwen Hu; Qian Wu; Yang Qiao; Peng Zhang; Wentao Dai; Hongyue Tao; Shuang Chen
Journal:  Cartilage       Date:  2020-05-22       Impact factor: 3.117

Review 5.  Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review.

Authors:  Gergő A Molnár; Szilárd Kun; Eszter Sélley; Melinda Kertész; Lívia Szélig; Csaba Csontos; Katalin Böddi; Lajos Bogár; Attila Miseta; István Wittmann
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

6.  Insulin Therapy of Nondiabetic Septic Patients Is Predicted by para-Tyrosine/Phenylalanine Ratio and by Hydroxyl Radical-Derived Products of Phenylalanine.

Authors:  Szilárd Kun; Gergő A Molnár; Eszter Sélley; Lívia Szélig; Lajos Bogár; Csaba Csontos; Attila Miseta; István Wittmann
Journal:  Oxid Med Cell Longev       Date:  2015-10-20       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.